Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia

被引：20
|
作者：
Sahin, Ilyas [1 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 12期
关键词：
D O I：
10.1056/NEJMc1809507
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1186 / 1186
页数：1
相关论文
共 50 条
  • [31] Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma
    Chmielewska, Agnieszka
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 286 - 290
  • [32] Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
    Roboz, Gail J.
    DiNardo, Courtney D.
    Stein, Eytan M.
    de Botton, Stephane
    Mims, Alice S.
    Prince, Gabrielle T.
    Altman, Jessica K.
    Arellano, Martha L.
    Donnellan, Will
    Erba, Harry P.
    Mannis, Gabriel N.
    Pollyea, Daniel A.
    Stein, Anthony S.
    Uy, Geoffrey L.
    Watts, Justin M.
    Fathi, Amir T.
    Kantarjian, Hagop M.
    Tallman, Martin S.
    Choe, Sung
    Dai, David
    Fan, Bin
    Wang, Hongfang
    Zhang, Vickie
    Yen, Katharine E.
    Kapsalis, Stephanie M.
    Hickman, Denice
    Liu, Hua
    Agresta, Samuel, V
    Wu, Bin
    Attar, Eyal C.
    Stone, Richard M.
    BLOOD, 2020, 135 (07) : 463 - 471
  • [33] Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
    Watts, Justin M.
    Baer, Maria R.
    Yang, Jay
    Prebet, Thomas
    Lee, Sangmin
    Schiller, Gary J.
    Dinner, Shira N.
    Pigneux, Arnaud
    Montesinos, Pau
    Wang, Eunice S.
    Seiter, Karen P.
    Wei, Andrew H.
    De Botton, Stephane
    Arnan, Montserrat
    Donnellan, Will
    Schwarer, Anthony P.
    Recher, Christian
    Jonas, Brian A.
    Ferrell Jr, P. Brent
    Marzac, Christophe
    Kelly, Patrick
    Sweeney, Jennifer
    Forsyth, Sanjeev
    Guichard, Sylvie M.
    Brevard, Julie
    Henrick, Patrick
    Mohamed, Hesham
    Cortes, Jorge E.
    LANCET HAEMATOLOGY, 2023, 10 (01): : E46 - E58
  • [34] Longitudinal Molecular Profiling in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib
    Choe, Sung
    Wang, Hongfang
    Roboz, Gail J.
    DiNardo, Courtney D.
    Stein, Eytan M.
    Mims, Alice S.
    Prince, Gabrielle T.
    Watts, Justin M.
    Fan, Bin
    Nejad, Parham
    Zhang, Vickie
    Liu, Hua
    Attar, Eyal C.
    Wu, Bin
    Stone, Richard M.
    BLOOD, 2020, 136
  • [35] Evaluating ivosidenib for the treatment of acute myeloid leukemia
    Donker, M. L.
    Ossenkoppele, G. J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (18) : 2205 - 2213
  • [36] TRIPTOLIDE, A NOVEL THERAPEUTIC AGENT FOR IDH1-MUTATED GLIOMA
    Yu, Di
    Liu, Yang
    Xu, Guowang
    Yang, Chunzhang
    NEURO-ONCOLOGY, 2019, 21 : 82 - 82
  • [37] TARGETING IDH1-MUTATED OLIGODENDROGLIOMA WITH ACID CERAMIDASE INHIBITORS
    Vilamu, Helena Muley
    Dowdy, Tyrone
    Zaibaq, Faris
    Larion, Mioara
    NEURO-ONCOLOGY, 2024, 26
  • [38] Mutant IDH (mIDH) inhibitors, ivosidenib or enasidenib, with azacitidine (AZA) in patients with acute myeloid leukemia (AML).
    Dinardo, Courtney Denton
    Stein, Anthony Selwyn
    Stein, Eytan M.
    Fathi, Amir Tahmasb
    Schuh, Andre C.
    Fernandez, Pau Montesinos
    Odenike, Olatoyosi
    Kantarjian, Hagop M.
    Stone, Richard M.
    Collins, Robert
    Martinelli, Giovanni
    Arnan, Montserrat
    Wu, Bin
    Koralek, Daniel O.
    Van Oostendorp, Jason
    Gong, Jing
    MacBeth, Kyle J.
    Vyas, Paresh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] A perioperative study of Safusidenib in patients with IDH1-mutated glioma
    Cain, Sarah A.
    Topp, Monique
    Rosenthal, Mark
    Tobler, Robert
    Freytag, Saskia
    Best, Sarah A.
    Whittle, James R.
    Drummond, Katharine J.
    FUTURE ONCOLOGY, 2024, 20 (33) : 2533 - 2545
  • [40] Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study
    DiNardo, Courtney D.
    Stein, Eytan M.
    de Botton, Stephane
    Roboz, Gail J.
    Altman, Jessica K.
    Mims, Alice S.
    Swords, Ronan
    Collins, Robert H.
    Mannis, Gabriel N.
    Pollyea, Daniel A.
    Donnellan, Will
    Fathi, Amir T.
    Pigneux, Arnaud
    Erba, Harry P.
    Prince, Gabrielle T.
    Stein, Anthony S.
    Uy, Geoffrey L.
    Foran, James M.
    Traer, Elie
    Stuart, Robert K.
    Arellano, Martha L.
    Slack, James L.
    Sekeres, Mikkael A.
    Willekens, Christophe
    Choe, Sung
    Wang, Hongfang
    Zhang, Vickie
    Yen, Katharine E.
    Kapsalis, Stephanie M.
    Yang, Hua
    Dai, David
    Fan, Bin
    Goldwasser, Meredith
    Liu, Hua
    Agresta, Sam
    Wu, Bin
    Attar, Eyal C.
    Tallman, Martin S.
    Stone, Richard M.
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S204 - S205
12345